Post on 05-Apr-2018
8/2/2019 Sehha Com Issue121 Apr12
1/45
1212012
http://www.Sehha.com
http://www.sehha.com/http://www.sehha.com/8/2/2019 Sehha Com Issue121 Apr12
2/45
Thyroid disorders..............................................................................1
Weaning................................................................................................5 ............................................................................................................9Ankle Sprain.......................................................................................................9
..........................................................................................................16 .........................................................................................................17
Gastric cancer....................................................................................................17 ..............................................................................................................30
( ) ...................................................................31
Risk of Narcotic Drugs (Atremadole or Atramale........................................................31 Penis size.....................................................................................35
................................................37 :.........................................................................................40
....................................................................................................42
.
.
http://www.sehha.com/http://www.sehha.com/products/p-size.htmhttp://www.sehha.com/products/p-size.htmhttp://www.sehha.com/products/p-size.htmhttp://www.sehha.com/products/p-size.htmhttp://www.sehha.com/products/p-size.htmhttp://www.sehha.com/products/p-size.htmhttp://www.sehha.com/products/p-size.htmhttp://www.sehha.com/products/p-size.htmhttp://www.sehha.com/products/p-size.htmhttp://www.sehha.com/products/p-size.htmhttp://www.sehha.com/products/p-size.htmhttp://www.sehha.com/products/p-size.htmhttp://www.sehha.com/products/p-size.htmhttp://www.sehha.com/products/p-size.htmhttp://www.sehha.com/products/p-size.htmhttp://www.sehha.com/products/p-size.htmhttp://www.sehha.com/products/p-size.htmhttp://www.sehha.com/products/p-size.htmhttp://www.sehha.com/products/p-size.htmhttp://www.sehha.com/products/p-size.htmhttp://www.sehha.com/shop/ar/hairhealth/lasercomb.htmlhttp://www.sehha.com/products/dc/index.htmhttp://www.koleldonia.com/Andromedical/andropenis.htmlhttp://www.sehha.com/products/pre-order.htmhttp://www.sehha.com/products/p-size.htmhttp://www.sehha.com/products/p-size.htmhttp://www.sehha.com/products/p-size.htmhttp://www.sehha.com/products/p-size.htmhttp://www.sehha.com/products/p-size.htmhttp://www.sehha.com/products/p-size.htmhttp://www.sehha.com/products/p-size.htmhttp://www.sehha.com/products/p-size.htmhttp://www.sehha.com/products/p-size.htmhttp://www.sehha.com/products/p-size.htmhttp://www.sehha.com/products/p-size.htmhttp://www.sehha.com/products/p-size.htm8/2/2019 Sehha Com Issue121 Apr12
3/45
Thyroiddisorders
:
- -
- -
- -
451http://www.sehha.com
http://www.sehha.com/products/p-size.htmhttp://www.sehha.com/products/p-size.htmhttp://www.sehha.com/products/p-size.htmhttp://www.sehha.com/products/p-size.htmhttp://www.sehha.com/products/p-size.htmhttp://www.sehha.com/products/p-size.htmhttp://www.sehha.com/products/p-size.htmhttp://www.sehha.com/products/p-size.htmhttp://www.sehha.com/products/p-size.htmhttp://www.sehha.com/products/p-size.htmhttp://www.sehha.com/products/p-size.htmhttp://www.sehha.com/products/p-size.htmhttp://www.sehha.com/diseases/endocrine/Thyr-gland.htmhttp://www.sehha.com/diseases/endocrine/Hypothyroidism.htmhttp://www.sehha.com/http://www.sehha.com/http://www.sehha.com/diseases/endocrine/Thyr-gland.htmhttp://www.sehha.com/diseases/endocrine/Hypothyroidism.htm8/2/2019 Sehha Com Issue121 Apr12
4/45
:
:
:
452http://www.sehha.com
http://www.sehha.com/diseases/endocrine/hyperthyroidism.htmhttp://www.sehha.com/diseases/endocrine/hyperthyroidism.htmhttp://www.sehha.com/diseases/endocrine/hyperthyroidism.htmhttp://www.sehha.com/http://www.sehha.com/http://www.sehha.com/diseases/endocrine/hyperthyroidism.htm8/2/2019 Sehha Com Issue121 Apr12
5/45
8/1 :
l
- -
453http://www.sehha.com
http://www.sehha.com/diseases/git/diarrhea/dia1.htmhttp://www.sehha.com/http://www.sehha.com/http://www.sehha.com/diseases/git/diarrhea/dia1.htm8/2/2019 Sehha Com Issue121 Apr12
6/45
l
m
l
l
454http://www.sehha.com
http://www.sehha.com/http://www.sehha.com/media/video/43/%D9%85%D8%B6%D8%A7%D8%B1-%D8%A7%D9%84%D8%AA%D8%AF%D8%AE%D9%8A%D9%86.htmlhttp://www.sehha.com/8/2/2019 Sehha Com Issue121 Apr12
7/45
Weaning
:
( )
( )
6
455http://www.sehha.com
http://www.sehha.com/pedissues/growth.htmhttp://www.sehha.com/http://www.sehha.com/http://www.sehha.com/pedissues/growth.htm8/2/2019 Sehha Com Issue121 Apr12
8/45
( ) 47
) )
5 )60 (
( ) ( ( ( ) 6
456http://www.sehha.com
http://www.sehha.com/pedissues/diarrhea/ped-dia1.htmhttp://www.sehha.com/pedissues/ped-constp.htmhttp://www.sehha.com/http://www.sehha.com/http://www.sehha.com/pedissues/diarrhea/ped-dia1.htmhttp://www.sehha.com/pedissues/ped-constp.htm8/2/2019 Sehha Com Issue121 Apr12
9/45
:
: 3:
5:
:
( )
457http://www.sehha.com
http://www.sehha.com/http://www.sehha.com/8/2/2019 Sehha Com Issue121 Apr12
10/45
.
:
Abrupt weaning ) )
3
Gradual weaning
( )
Partial weaning
Natural weaning
458http://www.sehha.com
http://www.sehha.com/pedissues/teething1.htmhttp://www.sehha.com/http://www.sehha.com/http://www.sehha.com/pedissues/teething1.htm8/2/2019 Sehha Com Issue121 Apr12
11/45
AnkeSprain
inversion-type twist | ) (
neurovascular compromise bone tenderness 6 fibula
. tibia
muscle spasm
elevation compression
distal 32talofibular ligament
3 555
459http://www.sehha.com
http://www.sehha.com/medical/injuries/injuries_toc.htmhttp://www.sehha.com/diseases/physio/index.htmhttp://www.sehha.com/http://www.sehha.com/http://www.sehha.com/medical/injuries/injuries_toc.htmhttp://www.sehha.com/diseases/physio/index.htm8/2/2019 Sehha Com Issue121 Apr12
12/45
stretch
) plantar flexion
dorsiflexion.
100
4510http://www.sehha.com
http://www.sehha.com/http://www.sehha.com/8/2/2019 Sehha Com Issue121 Apr12
13/45
anterior talofibular
calcaneofibular posterior talofibular
% 5 %inversion sprains 85deltoid ligament medial ligament eversion sprains
10 . %syndesmotic injuries
tensile limits
predisposing provocative.
proprioception.
4511http://www.sehha.com
http://www.sehha.com/http://www.sehha.com/8/2/2019 Sehha Com Issue121 Apr12
14/45
.athletic competition
% 30
23,000
10,000
% 25
.
4512http://www.sehha.com
http://www.sehha.com/nutrition/sports/index.htmhttp://www.sehha.com/http://www.sehha.com/http://www.sehha.com/nutrition/sports/index.htmhttp://www.sehha.com/nutrition/sports/index.htm8/2/2019 Sehha Com Issue121 Apr12
15/45
|
4513http://www.sehha.com
http://www.sehha.com/http://www.sehha.com/8/2/2019 Sehha Com Issue121 Apr12
16/45
23
13
air splints .plastic braces
tissue healing
4514http://www.sehha.com
http://www.sehha.com/generalhealth/Analgesics_Antipyretics.htmhttp://www.sehha.com/http://www.sehha.com/http://www.sehha.com/generalhealth/Analgesics_Antipyretics.htm8/2/2019 Sehha Com Issue121 Apr12
17/45
23
.good stability
46
4515http://www.sehha.com
http://www.sehha.com/http://www.sehha.com/8/2/2019 Sehha Com Issue121 Apr12
18/45
4516http://www.sehha.com
http://www.sehha.com/http://www.sehha.com/diseases/rt/rt_toc.htmhttp://www.sehha.com/diseases/orthop/index.htmhttp://www.sehha.com/8/2/2019 Sehha Com Issue121 Apr12
19/45
Gastriccancer
1940
70 median age
74 Hispanic
4517http://www.sehha.com
http://www.sehha.com/diseases/cancer/Chemo/index.htmhttp://www.sehha.com/diseases/cancer/Chemo/index.htmhttp://www.sehha.com/http://www.sehha.com/http://www.sehha.com/diseases/cancer/Chemo/index.htm8/2/2019 Sehha Com Issue121 Apr12
20/45
,the cardia the body pylorus
parietal cells endocrine cells
4 : the mucosa thesubmucosa the muscularis the serosal.
ventral portion
4518http://www.sehha.com
http://www.sehha.com/http://www.sehha.com/8/2/2019 Sehha Com Issue121 Apr12
21/45
long axis 50 % 25 %10 %10 %
35 %
, diffuse type intestinal type
4519http://www.sehha.com
http://www.sehha.com/http://www.sehha.com/8/2/2019 Sehha Com Issue121 Apr12
22/45
adenocarcinoma
celiac artery
|
4520http://www.sehha.com
http://www.sehha.com/http://www.sehha.com/8/2/2019 Sehha Com Issue121 Apr12
23/45
splenic hilum
porta hepatis suprapancreatic nodal groups gastroduodenal areas.
:
: 2001 850,000 522,000 328,000
nonmelanoma skin cancers - 12,39 (%10,4,
%) (%17,8) (9,4%) (%8,8 (10,4
4521http://www.sehha.com
http://www.sehha.com/diseases/rt/NSCLC1.htmhttp://www.sehha.com/diseases/cancer/BC/index.htmhttp://www.sehha.com/diseases/cancer/crc/crc1.htmhttp://www.sehha.com/http://www.sehha.com/http://www.sehha.com/diseases/rt/NSCLC1.htmhttp://www.sehha.com/diseases/cancer/BC/index.htmhttp://www.sehha.com/diseases/cancer/crc/crc1.htm8/2/2019 Sehha Com Issue121 Apr12
24/45
5 3050 %1025 %
adjuvant therapy.
70 74
25 %31 %
32 %unstaged.
dysphagia melena,
4522http://www.sehha.com
http://www.sehha.com/http://www.sehha.com/8/2/2019 Sehha Com Issue121 Apr12
25/45
peritoneal and pleural effusions
cachexia jaundice anastomosis
)Sister Mary Joseph nodule (
acanthosis nigricans circinate erythemas
peripheral thrombophlebitis .microangiopathic hemolytic anemia
pernicious anemia adenomatous polyps
chronic atrophic gastritis inheritedsyndromes
4523http://www.sehha.com
http://www.sehha.com/generalhealth/smoking_toc.htmhttp://www.sehha.com/generalhealth/smoking_toc.htmhttp://www.sehha.com/http://www.sehha.com/http://www.sehha.com/generalhealth/smoking_toc.htm8/2/2019 Sehha Com Issue121 Apr12
26/45
Helicobacter pylori 50 %5 %
10 %
30 %
carcinoembryonic antigen
% 4550
4524http://www.sehha.com
http://www.sehha.com/diseases/obesity/obesity01.htmhttp://www.sehha.com/medical/investigation/CBC.htmhttp://www.sehha.com/http://www.sehha.com/http://www.sehha.com/diseases/obesity/obesity01.htmhttp://www.sehha.com/medical/investigation/CBC.htm8/2/2019 Sehha Com Issue121 Apr12
27/45
cancer antigen 19-920 %
endoscopic ultrasound.
4525http://www.sehha.com
http://www.sehha.com/http://www.sehha.com/8/2/2019 Sehha Com Issue121 Apr12
28/45
4526http://www.sehha.com
http://www.sehha.com/http://www.sehha.com/8/2/2019 Sehha Com Issue121 Apr12
29/45
adenocarcinoma 9095 % tubular papillary
mucinous signet-ring undifferentiated
ulcerative polypoid scirrhous superficial spreading multicentric Barrett
ectopic adenocarcinoma
Immunohistochemistry specific antibody antigen
) intestinal () diffuse )
4527http://www.sehha.com
http://www.sehha.com/http://www.sehha.com/8/2/2019 Sehha Com Issue121 Apr12
30/45
Lymphoma Leiomyosarcoma.
total gastrectomy subtotal gastrectomy
distal carcinomas
5 survival rates
bypass operation
- -
4528http://www.sehha.com
http://www.sehha.com/http://www.sehha.com/8/2/2019 Sehha Com Issue121 Apr12
31/45
5 6090 %3050
1025 %
local and systemic relapse.
) ,cyclophosphamide
vincristine doxorubicin (rituximab 5 4060 %
30 12.
anastomotic failure ( )ileus
|thromboembolism.
dumping syndrome 12 reflux esophagitis .
4529http://www.sehha.com
http://www.sehha.com/diseases/orthop/osteop/index.htmhttp://www.sehha.com/http://www.sehha.com/http://www.sehha.com/diseases/orthop/osteop/index.htm8/2/2019 Sehha Com Issue121 Apr12
32/45
15 %5
4530http://www.sehha.com
http://www.sehha.com/http://www.sehha.com/8/2/2019 Sehha Com Issue121 Apr12
33/45
( )
RiskofNarcoticDrugsAtreadoeorAtraae
( ) 20 40
100mg50mg l200mg225mg500mg l
225mg200mg100mg
%) 3 ( Atramale Atremadole
parkinol lysergic acid diethylamide
( )
1.
2.
3.
: lHealth risks
:l
:
: :
4531http://www.sehha.com
http://www.sehha.com/http://www.sehha.com/8/2/2019 Sehha Com Issue121 Apr12
34/45
:()
: l
:
. :
: .
:
:
:
: lPsychological risks
2040
() l
) :
( l ""
" " " "
4532http://www.sehha.com
http://www.sehha.com/diseases/git/git.htmhttp://www.sehha.com/diseases/git/git.htmhttp://www.sehha.com/diseases/git/pu/index.htmhttp://www.sehha.com/diseases/id/flu/flu01.htmhttp://www.sehha.com/diseases/id/flu/flu01.htmhttp://www.sehha.com/pedissues/commoncold.htmhttp:/www.sehha.com/diseases/id/flu/flu01.htmhttp://www.sehha.com/medical/body-pics/UrinaryBladder.htmhttp://www.sehha.com/diseases/ut/kidney.htmhttp://www.sehha.com/medical/Anatomy/Eye_Anatomy01.htmhttp://www.sehha.com/medical/Anatomy/Eye_Anatomy08.htmhttp://www.sehha.com/diseases/cvs/circ2.htmhttp://www.sehha.com/diseases/cvs/circ2.htmhttp://www.sehha.com/mentalhealth/anxiety-stress.htmhttp://www.sehha.com/http://www.sehha.com/http://www.sehha.com/diseases/git/git.htmhttp://www.sehha.com/diseases/git/pu/index.htmhttp://www.sehha.com/diseases/id/flu/flu01.htmhttp://www.sehha.com/pedissues/commoncold.htmhttp:/www.sehha.com/diseases/id/flu/flu01.htmhttp://www.sehha.com/medical/body-pics/UrinaryBladder.htmhttp://www.sehha.com/diseases/ut/kidney.htmhttp://www.sehha.com/medical/Anatomy/Eye_Anatomy01.htmhttp://www.sehha.com/medical/Anatomy/Eye_Anatomy08.htmhttp://www.sehha.com/diseases/cvs/circ2.htmhttp://www.sehha.com/mentalhealth/anxiety-stress.htm8/2/2019 Sehha Com Issue121 Apr12
35/45
l
l l
19642011World Health Organization in
1964-the year 2011.
: lSocial risks
(
| l l l ll
:
4533http://www.sehha.com
http://www.sehha.com/generalhealth/Narcotics.htmhttp://www.sehha.com/http://www.sehha.com/http://www.sehha.com/generalhealth/Narcotics.htm8/2/2019 Sehha Com Issue121 Apr12
36/45
l 50 $ 100 $
50 2 630 $ l 1520: $
:
:
:
:
4534http://www.sehha.com
http://www.sehha.com/http://www.sehha.com/media/video/89/%D9%85%D8%B5%D8%A7%D8%AF%D8%B1-%D8%A7%D9%84%D9%81%D9%8A%D8%AA%D8%A7%D9%85%D9%8A%D9%86%D8%A7%D8%AA-%D9%88%D8%A7%D9%84%D9%85%D8%B9%D8%A7%D8%AF%D9%86.htmlhttp://www.sehha.com/8/2/2019 Sehha Com Issue121 Apr12
37/45
Penissize
|
4535http://www.sehha.com
http://www.sehha.com/http://www.sehha.com/8/2/2019 Sehha Com Issue121 Apr12
38/45
14 1018
68
( ) ( )
) | 68 (7.5
(
4536http://www.sehha.com
http://www.sehha.com/products/p-size.htmhttp://www.sehha.com/http://www.sehha.com/http://www.sehha.com/products/p-size.htm8/2/2019 Sehha Com Issue121 Apr12
39/45
:
l
| .Panic altack
:
l :
:
: l
:
4537http://www.sehha.com
http://www.sehha.com/mentalhealth/anxiety-stress.htmhttp://www.sehha.com/http://www.sehha.com/http://www.sehha.com/mentalhealth/anxiety-stress.htm8/2/2019 Sehha Com Issue121 Apr12
40/45
l
1.
l
l l
.2 l |
|
3.
4.
5. l ll
6.
7.
4538http://www.sehha.com
http://www.sehha.com/http://www.sehha.com/8/2/2019 Sehha Com Issue121 Apr12
41/45
8. | 510
9. 10.
11.
12.
13.
4539http://www.sehha.com
http://www.sehha.com/http://www.sehha.com/Glossary/index.phphttp://www.sehha.com/8/2/2019 Sehha Com Issue121 Apr12
42/45
) (
.1 .2
.3
( )
4540http://www.sehha.com
http://www.sehha.com/http://www.sehha.com/8/2/2019 Sehha Com Issue121 Apr12
43/45
) (
:
1. 2.
.3
4.
.5
25
4541http://www.sehha.com
http://www.sehha.com/http://www.sehha.com/8/2/2019 Sehha Com Issue121 Apr12
44/45
6
4542http://www.sehha.com
http://www.sehha.com/http://www.sehha.com/8/2/2019 Sehha Com Issue121 Apr12
45/45
http://sehha.com/feedback.htm